[H2-receptor antagonists and the incidence of gastroduodenal ulcer perforation and hemorrhage. An epidemiological study].
The only curative treatment to proximal bile duct cancers with involvement of both hepatic ducts is liver transplantation. A curative resection with wide lateral clearance is limited due to the neighbourhood of vital anatomic structures in the liver hilum. The majority of patients with bile duct cancers is over 60 years of age and due to concomitant disease, they do not fulfill the requirements for liver transplantation. Our treatment strategy in adequate cases is palliative tumor resection and reconstruction of bile passage by sutureless biliodigestive anastomosis as proposed by Rodney Smith. We treated 11 patients with this method, in 5 patients an additive combined radiotherapy by percutaneous radiation and intraluminal after-loading therapy was performed. Our results indicate that this strategy leads to effective palliation in cases provided that only microscopic residual tumor is left in situ (R1-resection). Our observed survival times compare favorably to survival times after liver transplantation (average survival time 11.5 months median survival time 10 months).
Meissner
K
K
Chirurgische Abteilung, Allgemeines öffentliches Krankenhaus, Tamsweg.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003710:Demography; D004812:Epidemiologic Methods; D005260:Female; D005860:Germany, West / Q000453:epidemiology; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010438:Peptic Ulcer Hemorrhage / Q000453:epidemiology* / Q000517:prevention & control; D010439:Peptic Ulcer Perforation / Q000453:epidemiology* / Q000517:prevention & control; D012189:Retrospective Studies
D006635:Histamine H2 Antagonists
H2-Receptorantagonisten und die Incidenz gastroduodenaler Ulcusperforationen und -blutungen. Eine epidemiologische Studie.